28 septiembre 2015
A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues a family physician and comparative effectiveness researcher.
http://www.sciencedaily.com/releases/2015/09/150928123312.htm
